Research
My research aims to better define the clinical heterogeneity of Parkinson’s disease and to understand the neurobiological basis of this, with the ultimate goal of developing more targeted therapeutic strategies for different PD subtypes. Using epidemiological, functional MRI and genetic approaches, my work to date has defined and characterised distinct cognitive syndromes in PD, and developed prognostic tools for dementia risk and poor outcome which can be used for early stratification. My group is currently investigating the role of the immune system in mediating heterogeneity of outcome in PD, through clinicopathological work, PET neuroimaging and studies of peripheral immune function in PD patients.
Publications
Key publications:
A full list of publications can be found at
